ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...
Emerging neurotechnologies—devices and techniques designed to collect information about the brain or affect its function—are becoming increasingly important due to scientific and technological ...
Neuromodulation has been a fast-growing area of medicine for at least a decade. Despite becoming an increasingly common way to treat chronic pain, neurological disorders, and even psychiatric ...
Experts are already treating addicted people with at-home neuromodulation devices to control cravings, and the future is ...
First customer sites include the University of Arkansas for Medical Sciences, MUSC Health, and Calif.-based Acacia Clinics and Kaizen Brain Center BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, ...
Medtronic will acquire SPR Therapeutics for $650 million, adding the FDA-cleared SPRINT PNS System for temporary PNS to its ...
SAN CLEMENTE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results